Saturday, May 8, 2021 |
Partly Cloudy

Md. offers COVID-19 antibody treatment to high-risk patients with mild symptoms

January 28, 2021
This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by coronaviruses. Note the spikes that adorn the outer surface of the virus, which impart the look of a corona surrounding the virion, when viewed electron microscopically. A novel coronavirus, named Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China in 2019. The illness caused by this virus has been named coronavirus disease 2019 (COVID-19).

There’s a relatively new treatment for certain COVID-19 patients that Maryland’s Health Department is making available for residents to consider. Monoclonal antibody therapy can help prevent mild COVID-19 symptoms from developing into issues that are more serious. The Food and Drug Administration approved its use in November for people 65-years-old and up or younger people with chronic medical conditions such as kidney disease, diabetes, heart disease or chronic lung disease.

Article Source: WTOP

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.